PNC Financial Services Group
UBX

PNC Financial Services Group’s Unity Biotechnology UBX Stock Holding History

PNC Financial Services Group’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-150
Closed -$383 – 4764
2023
Q2 		$383 Hold
150
– – ﹤0.01% 4615
2023
Q1 		$245 Hold
150
– – ﹤0.01% 4584
2022
Q4 		$411 Hold
150
– – ﹤0.01% 4553
2022
Q3 		$1K Hold
150
– – ﹤0.01% 4353
2022
Q2 		$1K Buy
+150
New +$1.25K ﹤0.01% 4384

Other funds holding UBX

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PNC Financial Services Group's UBX Position: Q3 2023 in Review

PNC Financial Services Group sold out of Unity Biotechnology (UBX) in Q3 2023, closing a stake of 150 shares — an estimated $383 sold.

PNC Financial Services Group first reported a position in UBX in Q2 2022 and held it in 5 quarters. The position peaked at $1K in Q3 2022. 36 funds tracked by Wall St. Rank hold UBX as of Q3 2023.

  • PNC Financial Services Group reported no remaining Unity Biotechnology position as of Q3 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 150 Unity Biotechnology shares in Q3 2023, an estimated $383.
  • PNC Financial Services Group first reported a position in Unity Biotechnology in Q2 2022 and held it in 5 quarters.
  • PNC Financial Services Group's Unity Biotechnology position peaked at $1K in Q3 2022.
  • 36 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2023.

Based on PNC Financial Services Group's 13F filing for Q3 2023, filed 13 Nov 2023.